Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSTV Plus Therapeutics, Inc.

已收盘 12-04 16:00:00 EST

0.6550

+0.0582

+9.75%

盘后0.6589

+0.0039+0.60%

19:58 EST

最高0.6600	最低0.5998	成交量927.52万
今开0.5998	昨收0.5968	日振幅10.09%
总市值9,002万	流通市值8,974万	总股本1.37亿
成交额585.70万	换手率6.77%	流通股本1.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSTV","market":"US","secType":"STK","nameCN":"Plus Therapeutics, Inc.","latestPrice":0.655,"timestamp":1764882000000,"preClose":0.5968,"halted":0,"volume":9275245,"hourTrading":{"tag":"盘后","latestPrice":0.6589,"preClose":0.655,"latestTime":"19:58 EST","volume":217923,"amount":142941.854598,"timestamp":1764896286007},"delay":0,"floatShares":137000000,"shares":137429055,"eps":-1.197913,"marketStatus":"已收盘","change":0.0582,"latestTime":"12-04 16:00:00 EST","open":0.5998,"high":0.66,"low":0.5998,"amount":5856986.647768,"amplitude":0.100871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.197913,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1764925200000},"marketStatusCode":5,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":0.5968,"preHourTrading":{"tag":"盘前","latestPrice":0.5998,"preClose":0.5968,"latestTime":"09:28 EST","volume":513576,"amount":307774.695413,"timestamp":1764858488275},"postHourTrading":{"tag":"盘后","latestPrice":0.6589,"preClose":0.655,"latestTime":"19:58 EST","volume":217923,"amount":142941.854598,"timestamp":1764896286007},"volumeRatio":2.056048},"requestUrl":"/m/hq/s/PSTV","defaultTab":"news","newsList":[{"id":"1146756785","title":"Plus Therapeutics完成与美国FDA关于Reyobiq™在蛛网膜转移治疗中的未来临床开发计划的会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1146756785","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146756785?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:31","pubTimestamp":1763987501,"startTime":"0","endTime":"0","summary":"Plus Therapeutics完成与美国FDA关于Reyobiq™在蛛网膜转移治疗中的未来临床开发计划的会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSTV"],"gpt_icon":0},{"id":"1166739546","title":"Plus Therapeutics与哈门那达成国家覆盖协议，适用于Cnside®脑脊液检测以诊断转移性中枢神经系统癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=1166739546","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166739546?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:31","pubTimestamp":1763641904,"startTime":"0","endTime":"0","summary":"Plus Therapeutics与哈门那达成国家覆盖协议，适用于Cnside®脑脊液检测以诊断转移性中枢神经系统癌症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","LU0348723411.USD","PSTV","BK4533","LU0417517546.SGD","SG9999014021.USD","LU0070302665.USD","BK4139","LU0266013472.USD","LU0390134368.USD","LU0211331839.USD","SG9999014013.SGD","LU0256863811.USD","LU1093756325.SGD","LU1093756168.USD","HUM","LU0170899867.USD","SG9999014005.SGD","BK4566","BK4154","LU0208291251.USD","BK4585","LU0238689110.USD","BK4588","LU1983260115.SGD"],"gpt_icon":0},{"id":"1159198910","title":"Plus Therapeutics第三季度净亏损442.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159198910","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159198910?lang=zh_cn&edition=full","pubTime":"2025-10-31 04:34","pubTimestamp":1761856445,"startTime":"0","endTime":"0","summary":"10月30日 - Plus Therapeutics第三季度运营支出为587.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSTV","BK4139"],"gpt_icon":0},{"id":"1119944038","title":"Plus Therapeutics, Inc.与联合健康保险公司就转移性中枢神经系统癌症Cnside®脑脊液检测达成全国覆盖协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1119944038","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119944038?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:31","pubTimestamp":1758799881,"startTime":"0","endTime":"0","summary":"Plus Therapeutics, Inc.与联合健康保险公司就转移性中枢神经系统癌症Cnside®脑脊液检测达成全国覆盖协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU0545039389.USD","LU1069347547.HKD","LU2087625088.SGD","IE0009355771.USD","LU1988902786.USD","LU0689472784.USD","SG9999014880.SGD","IE00B1BXHZ80.USD","LU1506573853.SGD","LU1074936037.SGD","LU0965509101.SGD","LU0011850046.USD","LU0557290698.USD","LU1153585028.USD","LU0211326839.USD","LU0052756011.USD","LU1551013342.USD","LU2089284900.SGD","LU0107464264.USD","LU1267930573.SGD","LU0158827948.USD","LU1720051017.SGD","LU2023251221.USD","BK4532","LU0149725797.USD","LU1934455277.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU2347655156.SGD","LU2361044865.SGD","SG9999017495.SGD","LU1323610961.USD","BK4566","BK4154","LU0661504455.SGD","LU1035773651.USD","LU0310799852.SGD","LU1778281490.HKD","LU2125154935.USD","LU0122379950.USD","LU0820561818.USD","LU0882574055.USD","LU1037948541.HKD","IE00B19Z9505.USD","IE00B4JS1V06.HKD","LU0094547139.USD","LU0795875086.SGD","SGXZ57979304.SGD","LU1814569148.SGD","SGXZ99366536.SGD","LU0187121727.USD","LU1066051498.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","LU2552382058.USD","SG9999018865.SGD","LU2361045086.USD","SG9999001176.SGD","IE00BZ9MQY76.HKD","LU2089283258.USD","LU0553294199.USD","LU1066053197.SGD","LU2362541513.USD","LU0029864427.USD","IE00B7KXQ091.USD","IE00B19Z8W00.USD","LU1551013425.SGD","IE00B19Z9Z06.USD","LU0320765059.SGD","LU0672654240.SGD","LU0496365809.HKD","LU0820561909.HKD","IE00BFSS8Q28.SGD","IE00B2B36J28.USD","LU1674673691.USD","LU1720051108.HKD","LU0048584097.USD","LU2279689827.SGD","LU2324357040.USD","LU0079474960.USD","LU0289739699.SGD","SG9999014898.SGD","LU2125154778.USD","LU0109391861.USD","SG9999018857.SGD","IE00BKPKM429.USD","LU0234572021.USD","LU2360032135.SGD","LU0128525689.USD","LU0211327993.USD","LU0203347892.USD","LU1914381329.SGD","IE00B19Z9P08.USD","SG9999002232.USD","LU0211328371.USD","LU2362540622.SGD","LU0053666078.USD","LU1261432733.SGD","IE000M9KFDE8.USD","LU1066051225.USD","LU2264538146.SGD","LU0251132253.USD","LU1854104046.USD","LU0354030438.USD","LU1267930227.SGD","LU0316494557.USD","LU0310800379.SGD","LU1718418525.SGD","BK4534","IE00B894F039.SGD","LU2133065610.SGD","LU0310800965.SGD","LU1670627923.USD","LU1989771016.USD","LU2271345857.HKD","LU0353189680.USD","LU1119994496.HKD","LU0820562030.AUD","LU1066051811.HKD","LU2111349929.HKD","IE00B19Z3581.USD","LU2236285917.USD","LU1983299246.USD","IE0005OL40V9.USD","LU0238689110.USD","LU2028103732.USD","IE0002141913.USD","IE00B19Z8X17.USD","LU0345770993.USD","LU1854103824.USD","LU0787776722.HKD","LU0965509283.SGD","LU2552382132.HKD","LU1732800096.USD","LU0114720955.EUR","LU2242649171.HKD","LU0058720904.USD","LU0211326755.USD","LU2211815571.USD","LU2491049909.HKD","LU0256863811.USD","LU2361044949.HKD","LU0432979614.USD","LU0976567544.SGD","SGXZ51526630.SGD","LU0683600562.USD","LU0077335932.USD","LU0128525929.USD","LU1064131342.USD","LU0354030511.USD","IE0004445239.USD","LU0528227936.USD","LU0965509010.AUD","IE00B1XK9C88.USD","LU1934455194.USD","LU2357305700.SGD","IE00BJJMRZ35.SGD","IE0004445015.USD","IE00B775H168.HKD","LU1267930490.SGD","LU2112291526.USD","LU0708994859.HKD","LU0342679015.USD","SG9999013999.USD","LU1291159041.SGD","LU0708995401.HKD","LU0949170772.SGD","LU2461242641.AUD","IE00BJJMRX11.SGD","IE00B4R5TH58.HKD","BK4533","LU1732799900.SGD","SG9999001176.USD","LU0198837287.USD","LU0965508806.USD","IE00BFTCPJ56.SGD","LU0353189763.USD","IE00BFXG1179.USD","LU1061106388.HKD","LU0912757837.SGD","IE00BWXC8680.SGD","LU0943347566.SGD","LU0158827781.USD","LU1084165304.USD","LU1267930730.SGD","LU2552382215.SGD","LU0738911758.USD","BK4585","BK4581","LU1003077747.HKD","LU1791710400.SGD","UNH","LU1791710582.SGD","LU0203345920.USD","IE00B7SZLL34.SGD","IE00BN29S564.USD","SG9999014914.USD","LU1934455863.HKD","LU1674673428.USD","SG9999014906.USD","LU2491050154.USD","LU0823416689.USD","SGXZ31699556.SGD","BK4139","IE00BKVL7J92.USD","LU0861579265.USD","LU2089984988.USD","SGXZ81514606.USD","LU2244417387.USD","LU2468319806.SGD","LU2362541273.HKD","SG9999002224.SGD","LU0097036916.USD","LU0456855351.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","IE00BFSS7M15.SGD","LU1037948897.HKD","LU1023059063.AUD","LU1057294990.SGD","LU0795875169.SGD","IE00BSNM7G36.USD","LU1496350502.SGD","LU1670628061.USD","BK4588","LU0345770308.USD","PSTV","LU0417517546.SGD"],"gpt_icon":0},{"id":"2541129021","title":"Ascendiant Capital：维持Plus Therapeutics评级，由买入调整至买入评级, 目标价由20.00美元调整至20.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541129021","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541129021?lang=zh_cn&edition=full","pubTime":"2025-06-05 18:11","pubTimestamp":1749118309,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持Plus Therapeutics(PSTV.US)评级，由买入调整至买入评级, 目标价由20.00美元调整至20.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051816559772d461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051816559772d461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","LENZ"],"gpt_icon":0},{"id":"2517148026","title":"股价一夜飙涨逾300%！Plus Therapeutics(PSTV.US)肺癌患者软脑膜转移药物获FDA孤儿药认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2517148026","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517148026?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:49","pubTimestamp":1741308551,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Plus Therapeutics周四表示，其针对肺癌患者软脑膜转移的治疗药物Rhenium  Obisbemeda获得美国食品药品监督管理局孤儿药认定。受此提振，该公司股价周四收涨311.43%，盘后续涨超50%。FDA授予孤儿药认定的目的在于为针对罕见疾病和病症的药物研发者提供财务激励。除了临床试验费用的税收抵免和营销申请用户费用的豁免外，开发者还可以获得长达七年的美国市场独占权。Plus Therapeutics表示，这一认定是在公司近期完成早期单剂量试验后获得的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LENZ","PSTV"],"gpt_icon":0},{"id":"2517316983","title":"Plus Therapeutics, Inc.股价上涨63.46% 市值涨214.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517316983?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Plus Therapeutics, Inc.股票出现异动，股价快速上涨63.46%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为945.74%、102.53%、48.57%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223143abeb7782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223143abeb7782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTVZ","LENZ","PSTV"],"gpt_icon":0},{"id":"2517989943","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517989943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517989943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185095,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Plus Therapeutics, Inc.股票出现波动，股价急速上涨10.69%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为334.68%、252.30%、185.70%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Tango Therapeutics, Inc.，振幅分别为23.90%、13.51%、11.41%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223135a260c738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223135a260c738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","BK4139","LENZ","PSTVZ"],"gpt_icon":0},{"id":"2516963757","title":"Plus Therapeutics, Inc.盘中异动 急速跳水6.19%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516963757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516963757?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:50","pubTimestamp":1741013451,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时50分，Plus Therapeutics, Inc.股票出现波动，股价大幅下跌6.19%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为508.31%、113.64%、83.90%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为140.46%、70.53%、35.60%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225052a25d45b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225052a25d45b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTVZ","PSTV","BK4139"],"gpt_icon":0},{"id":"2514378873","title":"Plus Therapeutics, Inc.盘中异动 股价大涨5.04%报0.709美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378873?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Plus Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为484.61%、243.09%、63.65%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Ptc Therapeutics, Inc.、Enveric Biosciences, Inc.，振幅分别为31.14%、10.54%、9.91%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223244abe0eac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223244abe0eac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","LENZ","BK4139"],"gpt_icon":0},{"id":"2514386784","title":"Plus Therapeutics, Inc.盘中异动 大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386784?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:51","pubTimestamp":1740667894,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时51分，Plus Therapeutics, Inc.股票出现异动，股价快速跳水5.13%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272251349895145b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272251349895145b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","BK4139","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2514518988","title":"Plus Therapeutics, Inc.盘中异动 早盘大幅跳水9.26%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514518988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514518988?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580311,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Plus Therapeutics, Inc.股票出现异动，股价大幅跳水9.26%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2754.49%、115.31%、89.74%，振幅较大的相关个股有Enveric Biosciences, Inc.、Cns Pharmaceuticals, Inc.、Channel Therapeutics Corporation，振幅分别为25.42%、14.35%、10.67%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223151abddecb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223151abddecb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","LENZ","PSTVZ","BK4139"],"gpt_icon":0},{"id":"2514418350","title":"Plus Therapeutics, Inc.盘中异动 临近收盘股价大跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514418350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514418350?lang=zh_cn&edition=full","pubTime":"2025-02-26 05:01","pubTimestamp":1740517274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日05时01分，Plus Therapeutics, Inc.股票出现异动，股价急速下跌5.26%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Organovo Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2140.98%、1189.39%、1034.66%，振幅较大的相关个股有Organovo Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为241.19%、224.55%、127.49%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226050114a253df1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226050114a253df1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2513672784","title":"Plus Therapeutics, Inc.盘中异动 急速下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513672784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513672784?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Plus Therapeutics, Inc.股票出现波动，股价急速跳水5.32%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Biodexa Pharmaceuticals Plc、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为40.29%、24.06%、17.71%，振幅较大的相关个股有Gossamer Bio, Inc.、Summit Therapeutics Inc.、Estrella Immunopharma, Inc.，振幅分别为14.69%、12.61%、12.38%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223229a2521490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223229a2521490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","LENZ","BK4139","PSTVZ"],"gpt_icon":0},{"id":"2513216293","title":"Plus Therapeutics, Inc.盘中异动 下午盘大幅下跌5.65%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216293?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:46","pubTimestamp":1740163576,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时46分，Plus Therapeutics, Inc.股票出现异动，股价快速跳水5.65%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为286.34%、247.35%、136.41%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024616a24ee5ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024616a24ee5ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","LENZ","PSTV","BK4139"],"gpt_icon":0},{"id":"2512416549","title":"Plus Therapeutics, Inc.盘中异动 快速下跌5.65%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512416549?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Plus Therapeutics, Inc.股票出现异动，股价急速跳水5.65%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822360696279821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822360696279821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","LENZ","BK4139","PSTV"],"gpt_icon":0},{"id":"2511952505","title":"Plus Therapeutics, Inc.股价上涨12.50% 市值涨92.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511952505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511952505?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457191,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分，Plus Therapeutics, Inc.股票出现波动，股价快速上涨12.50%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Pliant Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为987.22%、815.82%、92.52%，振幅较大的相关个股有Edesa Biotech, Inc.、Fibrobiologics, Inc.、Pliant Therapeutics, Inc.，振幅分别为25.80%、16.76%、13.60%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223311a244abac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223311a244abac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2510395863","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨9.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510395863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510395863?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:40","pubTimestamp":1739288402,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时40分，Plus Therapeutics, Inc.股票出现波动，股价急速上涨9.01%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2701.01%、1069.47%、370.91%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234002a2420a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234002a2420a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2508142545","title":"Plus Therapeutics, Inc.盘中异动 早盘大幅下挫5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142545?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:07","pubTimestamp":1738595259,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时07分，Plus Therapeutics, Inc.股票出现波动，股价快速下挫5.24%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为501.09%、395.45%、260.47%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.56%、73.53%、50.76%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032307399879751a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032307399879751a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","LENZ","BK4139","PSTVZ"],"gpt_icon":0},{"id":"2508096043","title":"Plus Therapeutics, Inc.盘中异动 临近午盘股价大涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508096043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508096043?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:55","pubTimestamp":1738342541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时55分，Plus Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。其相关个股中，Cyclerion Therapeutics, Inc.、Calidi Biotherapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2135.29%、1940.28%、185.04%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为80.00%、56.30%、52.24%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201005541abbe5510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201005541abbe5510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://plustherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0025},{"period":"1month","weight":0.1528},{"period":"3month","weight":0.3271},{"period":"6month","weight":0.8335},{"period":"1year","weight":-0.5546},{"period":"ytd","weight":-0.481}],"compareEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0536},{"period":"6month","weight":0.1415},{"period":"1year","weight":0.1324},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Plus Therapeutics, Inc.该公司于1996年7月作为一家加利福尼亚普通合伙企业而组建，并于1997年5月在特拉华成立。初期，以MacroPore Biosurgery为名而被知晓，在此之前是MacroPore。该公司是一家美国制药公司，开发具有先进平台技术的中枢神经系统（“CNS”）癌症靶向放射治疗药物。该公司的新型放射性药物制剂和治疗候选药物旨在向肿瘤提供安全有效的辐射剂量。为了实现这一点，该公司开发了药物配方的创新方法，包括用纳米脂质体和微球封装铼同位素等放射性核素。","yearOnYearQuotes":[{"month":1,"riseRate":0.652174,"avgChangeRate":0.086434},{"month":2,"riseRate":0.521739,"avgChangeRate":0.019388},{"month":3,"riseRate":0.391304,"avgChangeRate":-0.044696},{"month":4,"riseRate":0.347826,"avgChangeRate":-0.02768},{"month":5,"riseRate":0.478261,"avgChangeRate":0.361181},{"month":6,"riseRate":0.25,"avgChangeRate":-0.076657},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.003883},{"month":8,"riseRate":0.291667,"avgChangeRate":-0.04175},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.030103},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.062759},{"month":11,"riseRate":0.375,"avgChangeRate":0.007725},{"month":12,"riseRate":0.375,"avgChangeRate":-0.022323}],"exchange":"NASDAQ","name":"Plus Therapeutics, Inc.","nameEN":"Plus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Plus Therapeutics, Inc.,PSTV,Plus Therapeutics, Inc.股票,Plus Therapeutics, Inc.股票老虎,Plus Therapeutics, Inc.股票老虎国际,Plus Therapeutics, Inc.行情,Plus Therapeutics, Inc.股票行情,Plus Therapeutics, Inc.股价,Plus Therapeutics, Inc.股市,Plus Therapeutics, Inc.股票价格,Plus Therapeutics, Inc.股票交易,Plus Therapeutics, Inc.股票购买,Plus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}